Yoshiya Yamada

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. doi request reprint A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy
    Yoshiya Yamada
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY Electronic address
    Brachytherapy 13:111-6. 2014
  2. doi request reprint Multidisciplinary management of recurrent chordomas
    Yoshiya Yamada
    Department of Radiation Oncology, Medical Oncology, Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA
    Curr Treat Options Oncol 14:442-53. 2013
  3. doi request reprint American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy
    Yoshiya Yamada
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Brachytherapy 11:20-32. 2012
  4. ncbi request reprint Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer
    Yoshiya Yamada
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Brachytherapy 5:157-64. 2006
  5. ncbi request reprint A review of image-guided intensity-modulated radiotherapy for spinal tumors
    Yoshiya Yamada
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Neurosurgery 61:226-35; discussion 235. 2007
  6. ncbi request reprint Image-guided intensity-modulated radiation therapy of spine tumors
    Yoshiya Yamada
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Curr Neurol Neurosci Rep 6:207-11. 2006
  7. ncbi request reprint Multifractionated image-guided and stereotactic intensity-modulated radiotherapy of paraspinal tumors: a preliminary report
    Yoshiya Yamada
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 62:53-61. 2005
  8. doi request reprint Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT
    Israel Deutsch
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center New York, New York, NY10021, USA
    Brachytherapy 9:313-8. 2010
  9. doi request reprint High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions
    Yoshiya Yamada
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 71:484-90. 2008
  10. ncbi request reprint Impact of intraoperative edema during transperineal permanent prostate brachytherapy on computer-optimized and preimplant planning techniques
    Yoshiya Yamada
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Clin Oncol 26:e130-5. 2003

Detail Information

Publications76

  1. doi request reprint A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy
    Yoshiya Yamada
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY Electronic address
    Brachytherapy 13:111-6. 2014
    ..We report the toxicity and biochemical tumor control outcome of a prospective Phase II study using high-dose-rate brachytherapy (HDR) alone as a salvage therapy for recurrent disease after external beam radiotherapy (EBRT)...
  2. doi request reprint Multidisciplinary management of recurrent chordomas
    Yoshiya Yamada
    Department of Radiation Oncology, Medical Oncology, Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA
    Curr Treat Options Oncol 14:442-53. 2013
    ..Nonetheless, advances in surgical, medical, and radiation oncology are providing new avenues of research and potentially may have significant impact upon successful salvage treatment...
  3. doi request reprint American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy
    Yoshiya Yamada
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Brachytherapy 11:20-32. 2012
    ..Most of the articles describe HDR as a boost with adjuvant external beam radiation, but there is a growing experience with HDR monotherapy...
  4. ncbi request reprint Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer
    Yoshiya Yamada
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Brachytherapy 5:157-64. 2006
    ..To report PSA relapse-free survival and toxicity outcomes of prostate cancer patients who have undergone three-dimensional computer-optimized high-dose-rate (HDR) brachytherapy with external beam radiotherapy as definitive treatment...
  5. ncbi request reprint A review of image-guided intensity-modulated radiotherapy for spinal tumors
    Yoshiya Yamada
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Neurosurgery 61:226-35; discussion 235. 2007
    ..Image-guided treatment tools such as cone beam computed tomography coupled with IMRT have reduced treatment errors associated with traditional radiotherapy, making highly accurate and conformal treatment feasible...
  6. ncbi request reprint Image-guided intensity-modulated radiation therapy of spine tumors
    Yoshiya Yamada
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Curr Neurol Neurosci Rep 6:207-11. 2006
    ..This review summarizes the significant contributions to the medical literature over the past calendar year...
  7. ncbi request reprint Multifractionated image-guided and stereotactic intensity-modulated radiotherapy of paraspinal tumors: a preliminary report
    Yoshiya Yamada
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 62:53-61. 2005
    ..This report presents clinical and physical data regarding the use of IMRT coupled with noninvasive body frames (stereotactic and image-guided) for multifractionated radiotherapy...
  8. doi request reprint Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT
    Israel Deutsch
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center New York, New York, NY10021, USA
    Brachytherapy 9:313-8. 2010
    ..a lower dose of IMRT combined with high-dose-rate (HDR) brachytherapy to increase the biologically effective dose of IMRT...
  9. doi request reprint High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions
    Yoshiya Yamada
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 71:484-90. 2008
    ..To report tumor control and toxicity for patients treated with image-guided intensity-modulated radiotherapy (RT) for spinal metastases with high-dose single-fraction RT...
  10. ncbi request reprint Impact of intraoperative edema during transperineal permanent prostate brachytherapy on computer-optimized and preimplant planning techniques
    Yoshiya Yamada
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Clin Oncol 26:e130-5. 2003
    ..Preplanned patients who encountered a greater degree of intraoperative edema had less %D90 target coverage...
  11. doi request reprint Local disease control for spinal metastases following "separation surgery" and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients
    Ilya Laufer
    Departments of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Neurosurg Spine 18:207-14. 2013
    ..The authors examine the outcomes of postoperative image-guided intensity-modulated radiation therapy delivered as single-fraction or hypofractionated stereotactic radiosurgery (SRS) for achieving long-term local tumor control...
  12. doi request reprint A comparison of the impact of isotope ((125)I vs. (103)Pd) on toxicity and biochemical outcome after interstitial brachytherapy and external beam radiation therapy for clinically localized prostate cancer
    Marisa A Kollmeier
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Brachytherapy 11:271-6. 2012
    ..To compare biochemical outcomes and morbidity associated with iodine-125 ((125)I) and palladium-103 ((103)Pd) brachytherapy as part of combined modality therapy for clinically localized prostate cancer...
  13. doi request reprint Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer
    Rupesh Kotecha
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Brachytherapy 12:44-9. 2013
    ....
  14. ncbi request reprint Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 67:65-70. 2007
    ..To report the 5-year tumor control and toxicity outcomes for patients with localized prostate treated with I-125 permanent implantation using an intraoperative real-time conformal planning technique...
  15. ncbi request reprint Intraoperative and percutaneous iridium-192 high-dose-rate brachytherapy for previously irradiated lesions of the spine
    Michael R Folkert
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
    Brachytherapy 12:449-56. 2013
    ..A novel high-dose-rate (HDR) brachytherapy technique has been developed to treat these previously irradiated lesions...
  16. doi request reprint Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma
    Lauren Q Shapiro
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Radiat Oncol Biol Phys 85:636-42. 2013
    ..The objective of this study was to characterize the patterns of failure after this treatment regimen...
  17. doi request reprint Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Brachytherapy 7:1-6. 2008
    ....
  18. ncbi request reprint Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine
    Michael R Folkert
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
    Int J Radiat Oncol Biol Phys 88:1085-91. 2014
    ..Hypofractionated (HF) and/or single-fraction (SF) image-guided stereotactic radiosurgery (IG-SRS) may provide a more effective means of managing these lesions...
  19. doi request reprint Favourable long-term outcomes with brachytherapy-based regimens in men ≤60 years with clinically localized prostate cancer
    Marisa A Kollmeier
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10028, USA
    BJU Int 111:1231-6. 2013
    ..To report long-term outcomes of men ≤60 years treated with brachytherapy (BT) for low- and intermediate-risk prostate cancer...
  20. doi request reprint Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan-Kettering Cancer Center experience
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Brachytherapy 11:245-9. 2012
    ..To identify predictors of biochemical tumor control and present an updated prognostic nomogram for patients with clinically localized prostate cancer treated with brachytherapy...
  21. doi request reprint Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 83:953-9. 2012
    ..To report the incidence and excess risk of second malignancy (SM) development compared with the general population after external beam radiotherapy (EBRT) and brachytherapy to treat prostate cancer...
  22. ncbi request reprint Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 55:956-63. 2003
    ..We report the preliminary outcome of patients with localized prostate cancer treated with this approach...
  23. ncbi request reprint Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 71:1028-33. 2008
    ..To report prostate-specific antigen (PSA) relapse-free survival and distant metastases-free survival (DMFS) outcomes for patients with clinically localized prostate cancer treated with high-dose conformal radiotherapy...
  24. doi request reprint Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases
    Carlo Greco
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 79:1151-7. 2011
    ..To report tumor local control after treatment with single-dose image-guided intensity-modulated radiotherapy (SD-IGRT) to extracranial metastatic sites...
  25. doi request reprint Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes
    Oren Cahlon
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 71:330-7. 2008
    ..To report toxicity and preliminary biochemical outcomes with high-dose intensity-modulated radiation therapy (IMRT) to a dose of 86.4 Gy for localized prostate cancer...
  26. ncbi request reprint A comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer
    Daniel E Spratt
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY Electronic address
    Brachytherapy 12:428-33. 2013
    ..Much of the justification for its adoption was derived from earlier clinical results using high-dose-rate (HDR) brachytherapy. We determine whether HDR's dosimetry can be achieved by virtual SBRT...
  27. pmc Correlation of local failure with measures of dose insufficiency in the high-dose single-fraction treatment of bony metastases
    D Michael Lovelock
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 77:1282-7. 2010
    ..We investigated the dependence of local control on measures of dose insufficiency...
  28. ncbi request reprint Intensity-modulated stereotactic radiotherapy of paraspinal tumors: a preliminary report
    Mark H Bilsky
    Neurosurgery Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Neurosurgery 54:823-30; discussion 830-1. 2004
    ..In this article, we report our initial clinical experience in treating 16 paraspinal tumors with IMRT in which the planning target volume was 2 mm or greater from the spinal cord...
  29. doi request reprint Intraoperative 32P high-dose rate brachytherapy of the dura for recurrent primary and metastatic intracranial and spinal tumors
    Michael R Folkert
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Neurosurgery 71:1003-10; discussion 1010-1. 2012
    ..Treatment of spinal and intracranial tumors with dural involvement is complicated by radiation tolerance of sensitive structures, especially in the setting of previous treatment...
  30. doi request reprint Short-term androgen-deprivation therapy improves prostate cancer-specific mortality in intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy
    Zachary S Zumsteg
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 85:1012-7. 2013
    ..We investigated the benefit of short-term androgen-deprivation therapy (ADT) in patients with intermediate-risk prostate cancer (PC) receiving dose-escalated external beam radiation therapy...
  31. pmc Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 82:1744-8. 2012
    ..To report tumor local progression-free outcomes after treatment with single-dose, image-guided, intensity-modulated radiotherapy and hypofractionated regimens for extracranial metastases from renal cell primary tumors...
  32. pmc Less-restrictive, patient-specific radiation safety precautions can be safely prescribed after permanent seed implantation
    Lawrence T Dauer
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Brachytherapy 9:101-11. 2010
    ..To use radiation exposure rate measurements to determine patient-specific radiation safety instructions with the aim of reducing unnecessary precaution times and to evaluate potential doses to members of the public...
  33. ncbi request reprint Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY10021, USA
    Radiother Oncol 84:185-9. 2007
    ..To report the dosimetric outcome of patients with clinically localized prostate cancer treated with I-125 permanent implantation using an intraoperative real-time conformal planning technique...
  34. doi request reprint A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases
    Cameron Brennan
    Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York
    Int J Radiat Oncol Biol Phys 88:130-6. 2014
    ..To evaluate local control after surgical resection and postoperative stereotactic radiosurgery (SRS) for brain metastases...
  35. pmc Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes
    Michael J Zelefsky
    Departments of Radiation Oncology, Medical Physics, and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Eur Urol 60:1133-9. 2011
    ..Higher radiation dose levels have been shown to be associated with improved tumor-control outcomes in localized prostate cancer (PCa) patients...
  36. pmc Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Urology 77:986-90. 2011
    ..To compare the long-term, prostate-specific antigen relapse-free survival outcome and incidence of toxicity for patients with low-risk prostate cancer who underwent brachytherapy or intensity-modulated radiotherapy (RT)...
  37. doi request reprint Impact of dose on local failure rates after image-guided reirradiation of recurrent paraspinal metastases
    Shari Damast
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 81:819-26. 2011
    ..To examine the impact of dose on local failure (LF) rates in the re-treatment of recurrent paraspinal metastases with image-guided intensity-modulated radiotherapy (IG-IMRT)...
  38. doi request reprint Repeat decompression surgery for recurrent spinal metastases
    Ilya Laufer
    Departments of Neurological Surgery, Memorial Sloan Kettering Cancer Center, New York, USA
    J Neurosurg Spine 13:109-15. 2010
    ..In carefully selected patients, reoperation can prolong ambulation and result in good functional and neurological outcomes...
  39. doi request reprint Postradiotherapy 2-year prostate-specific antigen nadir as a predictor of long-term prostate cancer mortality
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 75:1350-6. 2009
    ..To report the influence of posttreatment prostate-specific antigen (PSA) nadir response at 2 years after external beam radiotherapy (RT) on distant metastases (DM) and cause-specific mortality (CSM)...
  40. ncbi request reprint Accurate setup of paraspinal patients using a noninvasive patient immobilization cradle and portal imaging
    D Michael Lovelock
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Med Phys 32:2606-14. 2005
    ....
  41. doi request reprint Preliminary results of high-dose single-fraction radiotherapy for the management of chordomas of the spine and sacrum
    Yoshiya Yamada
    Departments of Radiation Oncology, Neurosurgery, Medical Physics, and Orthopedics, Memorial Sloan Kettering Cancer Center, New York, New York Department of Neurologic Surgery, Weill Cornell Medical College, New York, New York Departments of Medicine, Pediatrics, and Orthopedics, Mount Sinai School of Medicine, New York, New York
    Neurosurgery 73:673-80; discussion 680. 2013
    ..Furthermore, these tumors have shown resistance to fractionated photon radiation at conventional doses and numerous chemotherapies...
  42. doi request reprint International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery
    Brett W Cox
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Radiat Oncol Biol Phys 83:e597-605. 2012
    ..However, target volume definition varies considerably and no consensus target volume guidelines exist. This study proposes consensus target volume definitions using common scenarios in metastatic spine radiosurgery...
  43. doi request reprint Delivering a third course of radiation to spine metastases using image-guided, intensity-modulated radiation therapy
    Evangelia Katsoulakis
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Neurosurg Spine 18:63-8. 2013
    ..The objective of this study was to investigate the feasibility and safety of delivering a third course of radiation to patients with multiply recurrent metastatic disease to the spine...
  44. pmc Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery
    Brett W Cox
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Radiat Oncol Biol Phys 83:e661-7. 2012
    ..To report the esophageal toxicity from single-fraction paraspinal stereotactic radiosurgery (SRS) and identify dosimetric and clinical risk factors for toxicity...
  45. doi request reprint Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 70:1124-9. 2008
    ..To report the incidence and predictors of treatment-related toxicity at 10 years after three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT) for localized prostate cancer...
  46. ncbi request reprint Clinical outcomes after reirradiation of paraspinal tumors
    Jean L Wright
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Clin Oncol 29:495-502. 2006
    ..We present our experience with reirradiation of locally recurrent paraspinal tumors using image-guided intensity modulated radiotherapy (IG-IMRT)...
  47. pmc Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Clin Oncol 28:1508-13. 2010
    ..We assessed the effect of radical prostatectomy (RP) and external beam radiotherapy (EBRT) on distant metastases (DM) rates in patients with localized prostate cancer treated with RP or EBRT at a single specialized cancer center...
  48. ncbi request reprint A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy
    Zachary S Zumsteg
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Eur Urol 64:895-902. 2013
    ..The management of intermediate-risk prostate cancer (PCa) is controversial, in part due to the heterogeneous nature of patients falling within this classification...
  49. doi request reprint 32P brachytherapy conformal source model RIC-100 for high-dose-rate treatment of superficial disease: Monte Carlo calculations, diode measurements, and clinical implementation
    Gil ad N Cohen
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York Electronic address
    Int J Radiat Oncol Biol Phys 88:746-52. 2014
    ..A novel (32)P brachytherapy source has been in use at our institution intraoperatively for temporary radiation therapy of the spinal dura and other localized tumors. We describe the dosimetry and clinical implementation of the source...
  50. ncbi request reprint Image-guided intensity-modulated photon radiotherapy using multifractionated regimen to paraspinal chordomas and rare sarcomas
    Stephanie A Terezakis
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 69:1502-8. 2007
    ..We report our experience with multifractionated regimens using image-guided intensity-modulated radiotherapy to treat gross paraspinal disease to doses beyond cord tolerance...
  51. doi request reprint Benign notochordal cell tumors of the spine: natural history of 8 patients with histologically confirmed lesions
    J Bryan Iorgulescu
    Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Neurosurgery 73:411-6. 2013
    ....
  52. doi request reprint Abbreviated course of radiation therapy with concurrent temozolomide for high-grade glioma in patients of advanced age or poor functional status
    Marsha Reyngold
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    J Neurooncol 110:369-74. 2012
    ..Grade 3-4 hematologic toxicity occurred in 11 patients. Abbreviated RT with concurrent TMZ provides a clinical benefit, is safe and tolerable in patients of advanced age or poor functional status...
  53. doi request reprint Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy
    Marisa A Kollmeier
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 79:713-8. 2011
    ..To investigate the association between 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) and biochemical and survival outcomes after high-dose radiotherapy (RT) for prostate cancer...
  54. pmc The NOMS framework: approach to the treatment of spinal metastatic tumors
    Ilya Laufer
    Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Oncologist 18:744-51. 2013
    ....
  55. doi request reprint Prognostic importance of Gleason 7 disease among patients treated with external beam radiation therapy for prostate cancer: results of a detailed biopsy core analysis
    Daniel E Spratt
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Radiat Oncol Biol Phys 85:1254-61. 2013
    ..To analyze the effect of primary Gleason (pG) grade among a large cohort of Gleason 7 prostate cancer patients treated with external beam radiation therapy (EBRT)...
  56. pmc Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Radiother Oncol 93:414-8. 2009
    ..There has been an increase in the utilization of single-fraction stereotactic body radiation therapy (SBRT) to treat thoracic structures, but there have been few reports describing toxicity outcomes with this treatment...
  57. doi request reprint Comparison of kilovoltage cone-beam computed tomography with megavoltage projection pairs for paraspinal radiosurgery patient alignment and position verification
    Sergey A Kriminski
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 71:1572-80. 2008
    ..We investigated whether the use of kilovoltage cone-beam computed tomography (CBCT) imaging eliminates the need for marker implantation...
  58. doi request reprint Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer
    Zumre A Alicikus
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Cancer 117:1429-37. 2011
    ..The authors investigated long-term tumor control and toxicity outcomes after high-dose, intensity-modulated radiation therapy (IMRT) in patients who had clinically localized prostate cancer...
  59. doi request reprint Temporal relationship of post-operative radiotherapy with temozolomide and oncologic outcome for glioblastoma
    Daniel E Spratt
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 22, New York, NY, 10065, USA
    J Neurooncol 116:357-63. 2014
    ..Our data does not support the OS benefit previously seen in delayed RT when correcting for important covariates. We demonstrate a survival detriment with delaying RT post-surgery greater than 6 weeks on multivariate analysis...
  60. ncbi request reprint Radiation for primary spine tumors
    Mark H Bilsky
    Department of Neurosurgery, Box 71, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Neurosurg Clin N Am 19:119-23. 2008
    ..A combination of radiation techniques and advances in systemic therapy may ultimately provide improved local tumor control and cure for these treatment-resistant tumors...
  61. ncbi request reprint Motion monitoring for cranial frameless stereotactic radiosurgery using video-based three-dimensional optical surface imaging
    Guang Li
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA
    Med Phys 38:3981-94. 2011
    ....
  62. doi request reprint Optimization of collimator trajectory in volumetric modulated arc therapy: development and evaluation for paraspinal SBRT
    Pengpeng Zhang
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 77:591-9. 2010
    ..To develop a collimator trajectory optimization paradigm for volumetric modulated arc therapy (VMAT) and evaluate this technique in paraspinal stereotactic body radiation therapy (SBRT)...
  63. ncbi request reprint Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 176:1415-9. 2006
    ..We report on the long-term results and late toxicity outcomes of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer...
  64. pmc Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas
    Philip H Gutin
    Department of Neurosurgery, The Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Int J Radiat Oncol Biol Phys 75:156-63. 2009
    ..The objectives of this study were to determine the safety and activity of this combination in malignant gliomas...
  65. pmc Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery
    Dustin Boothe
    Department of Radiation Oncology, Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Neuro Oncol 15:1257-63. 2013
    ..The purpose of this study was to evaluate the treatment efficacy of cerebral RN to bevacizumab in patients with brain metastases previously treated with SRS...
  66. doi request reprint Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancer
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Eur Urol 53:1172-9. 2008
    ..To report the long-term tumor control and survival outcomes after conformal external-beam radiotherapy for patients with clinical stage T3 prostate cancer...
  67. pmc Temporary organ displacement coupled with image-guided, intensity-modulated radiotherapy for paraspinal tumors
    Evangelia Katsoulakis
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Radiat Oncol 8:150. 2013
    ..To investigate the feasibility and dosimetric improvements of a novel technique to temporarily displace critical structures in the pelvis and abdomen from tumor during high-dose radiotherapy...
  68. ncbi request reprint Assessment of radiation safety instructions to patients based on measured dose rates following prostate brachytherapy
    Lawrence T Dauer
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Brachytherapy 3:1-6. 2004
    ..To validate radiation safety instructions to patients and to evaluate the potential radiation doses to members of the public after (125)I or (103)Pd prostate implantation...
  69. ncbi request reprint High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 53:1111-6. 2002
    ..To report the acute and late toxicity and preliminary biochemical outcomes in 772 patients with clinically localized prostate cancer treated with high-dose intensity-modulated radiotherapy (IMRT)...
  70. doi request reprint Near-complete pathological response of chordoma to high-dose single-fraction radiotherapy: case report
    Abraham J Wu
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10022, USA
    Neurosurgery 64:E389-90; discussion E390. 2009
    ..Demonstration of biological effectiveness, as indicated by pathological response of a chordoma specimen after such radiotherapy, has not previously been reported...
  71. doi request reprint American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer
    Steven J Frank
    Department of Radiation Oncology, M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Brachytherapy 10:357-62. 2011
    ..The purpose of this review was to provide clarification on the appropriateness criteria and management considerations for the treatment of prostate cancer with permanent prostate brachytherapy...
  72. doi request reprint Reliability analysis of the epidural spinal cord compression scale
    Mark H Bilsky
    Departments of Neurosurgery, Box 71, 1275 York Ave, New York, New York 10065, USA
    J Neurosurg Spine 13:324-8. 2010
    ..The degree of ESCC often serves as a major determinant in the decision to operate or irradiate. The purpose of this study was to determine the reliability and validity of a 6-point, MR imaging-based grading system for ESCC...
  73. pmc Immunologic correlates of the abscopal effect in a patient with melanoma
    Michael A Postow
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    N Engl J Med 366:925-31. 2012
    ..Funded by the National Institutes of Health and others.)...
  74. ncbi request reprint Single-stage posterolateral transpedicular approach for resection of epidural metastatic spine tumors involving the vertebral body with circumferential reconstruction: results in 140 patients. Invited submission from the Joint Section Meeting on Disorders
    Jeremy C Wang
    Neurosurgery Service, Department of Epidemiology and Biostatistics, Rehabilitative Service at Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Neurosurg Spine 1:287-98. 2004
    ..The authors present their experience in using the single-stage posterolateral transpedicular approach (PTA) to decompress the spine circumferentially and to place instrumentation...
  75. ncbi request reprint Stereotactic radiosurgery and radiation therapy for spinal tumors
    Simon S Lo
    Department of Radiation Medicine, Ohio State University Medical Center, Columbus, OH 43210, USA
    Expert Rev Neurother 7:85-93. 2007
    ..Data on spinal stereotactic radiosurgery and radiotherapy have emerged in recent years. This review summarizes the clinical applications of stereotactic radiosurgery and radiotherapy for spinal tumors...